Skip to content
StockMarketAgent
Sector pending / HospitalsUpdated 2026-05-10 22:07 UTC

NSE/NEPHROCARE stock hub

NSE/NEPHROCARE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/NEPHROCAREis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.4B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/NEPHROCARE
In the news

Latest news · NSE/NEPHROCARE

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E53.5
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC5.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/NEPHROCARE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
156
Groups with data
11
Currency
INR
Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
334
Employees Change
207%
Employees Change Percent
163
Enterprise value
INR 1.3B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Hospitals
Last refreshed
2026-05-10
Market cap
INR 1.4B
Price
INR 86.3
Price currency
INR
Rev Per Employee
2,280,221.56x
Sic
8060
Symbol
nse/NEPHROCARE
Website
https://www.nephrocareindia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
2.17%
EV Earnings
41.48x
EV/EBIT
38.4x
EV/EBITDA
17.07x
EV/Sales
1.68x
P/B ratio
2.57x
P/E ratio
53.46x
P/S ratio
1.87x
PE Ratio3 Y
63.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
4.39%
EBITDA Margin
9.86%
Gross margin
53.42%
Gross Profit
INR 406.9M
Gross Profit Growth
31.32%
Gross Profit Growth Q
111.53%
Gross Profit Growth3 Y
55.3%
Net Income
INR 30.9M
Net Income Growth
-21.2%
Net Income Growth Q
-11.06%
Net Income Growth3 Y
9.22%
Pretax Margin
5.58%
Profit Margin
4.06%
Profit Per Employee
INR 92,558
Roa5y
13.23
Roe5y
79.37
ROIC
5.87
Roic5y
35.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
-36.16%
EPS Growth
-36.56
EPS Growth Q
-23.87
EPS Growth3 Y
-12.02
Revenue Growth
93.6x
Revenue Growth Q
122.32x
Revenue Growth3 Y
64.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Cash
INR 140.5M
Current Assets
INR 259.3M
Current Liabilities
INR 105.9M
Equity
INR 554.3M
Interest Coverage
28.57
Net Cash
INR 140.5M
Net Cash By Market Cap
INR 9.88
Net Cash Growth
374.78%
Net Debt EBITDA
INR -1.87
Net Debt Equity
INR -0.25
Tangible Book Value
INR 554.3M
Tangible Book Value Per Share
INR 33.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

1
MetricValue
Working Capital Turnover
INR 14.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-24.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-36.15%
200-day SMA
116.9
50-day SMA
73.44
50-day SMA vs 200-day SMA
50under200
All Time High
378.8
All Time High Change
-77.22%
All Time High Date
2024-07-31
All Time Low
50.05
All Time Low Change
72.43%
All Time Low Date
2026-03-30
ATR
5.04
Beta1y
1.49
Beta2y
0.92
Ch YTD
-21.9
High
87.95
High52
183
High52 Date
2025-08-25
High52ch
-52.84%
Low
86.05
Low52
50.05
Low52 Date
2026-03-30
Low52ch
72.43%
Ma50ch
17.51%
Price vs 200-day SMA
-26.17%
RSI
57.94
RSI Monthly
23.57
RSI Weekly
43.81
Sharpe ratio
-0.47x
Sortino ratio
-0.64
Total Return
-24.16%
Tr YTD
-21.9
Tr1m
37.53%
Tr1w
5.89%
Tr3m
-14.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
INR 33.4M
Operating Income Growth
-5.75
Operating Income Growth Q
-11.88
Operating Income Growth3 Y
8.14
Operating margin
4.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
5,698,400%
Shares Insiders
65.44%
Shares Institutions
5.95%
Shares Out
16,486,400
Shares Qo Q
0.05%
Shares Yo Y
24.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

45
MetricValue
Average Volume
20,680x
Bv Per Share
33.65
Ch1m
37.53
Ch1w
5.89
Ch1y
-36.15
Ch3m
-14.55
Ch6m
-32.58
Change
-1.6%
Change From Open
-1.6
Close
87.7
Days Gap
0
Depreciation Amortization
41,712,500
Dollar Volume
1,001,080
Earnings Date
2026-05-26
EBIT
INR 33.4M
EBITDA
INR 75.1M
EPS
INR 1.61
F Score
1
Fiscal Year End
March
Founded
2,014
Graham Number
34.96012
Graham Upside
-59.49
Income Tax
INR 11.6M
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-09-30
Lynch Fair Value
INR 14.89
Lynch Upside
-82.75
Ma150
106.3
Ma150ch
-18.81%
Ma20
84.3
Ma20ch
2.37%
Next Earnings Date
2026-05-26
Open
87.7
Position In Range
13.16
Ppne
347,661,000
Price Date
2026-05-08
Price EBITDA
INR 18.94
Ptbv Ratio
2.57
Relative Volume
0.56x
Revenue
761,594,000x
Tax By Revenue
1.52x
Tax Rate
27.3%
Tr6m
-32.58%
Volume
11,600
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NSE/NEPHROCARE pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/NEPHROCARE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-36.1%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NSE/NEPHROCARE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.9%
Share of float held by funds and institutions
Insider ownership
+65.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+24.2%
Negative means the company is buying back shares.
Technical

NSE/NEPHROCARE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
57.9
Neutral momentum band
Price vs 200-day MA
-26.2%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.47
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/NEPHROCARE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NEPHROCARE stock rating?

nse/NEPHROCARE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NEPHROCARE analysis?

The full report lives at /stocks/nse/NEPHROCARE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NEPHROCARE?

The latest report frames nse/NEPHROCARE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NEPHROCARE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.